Intriguing findings came from a study where PD risk could be predicted by measuring pS1292 levels in a small cohort of male G2019S carriers with PD, which were ~5-fold higher compared to PD non-carriers when normalised to total LRRK2 [117]. Here, LRRK2 is linked to Parkinson disease.